Literature DB >> 11477134

What we could do now: molecular pathology of gynaecological cancer.

C S Herrington1.   

Abstract

Gynaecological tumours exemplify many of the molecular paradigms of carcinogenesis. The clinical value of many of the molecular abnormalities present is now being tested and it is likely that the identification of at least some of these will become routine in the near future. This may help to refine diagnosis and guide treatment-for example, therapeutic vaccination for human papillomavirus related disease.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11477134      PMCID： PMC1187070          DOI： 10.1136/mp.54.4.222

Source DB:  PubMed          Journal:  Mol Pathol        ISSN： 1366-8714


  20 in total

Review 1.  Cervical pathology.

Authors:  C S Herrington
Journal:  Curr Opin Obstet Gynecol       Date:  1997-02       Impact factor: 1.927

2.  DNA content and S-phase fraction in epithelial ovarian cancer: what information do they really add?

Authors:  P Braly
Journal:  Gynecol Oncol       Date:  1998-10       Impact factor: 5.482

3.  PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.

Authors:  R L Levine; C B Cargile; M S Blazes; B van Rees; R J Kurman; L H Ellenson
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

4.  K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.

Authors:  G L Mutter; H Wada; W C Faquin; T Enomoto
Journal:  Mol Pathol       Date:  1999-10

5.  Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.

Authors:  J P Packenham; S du Manoir; E Schrock; J I Risinger; D Dixon; D N Denz; J A Evans; A Berchuck; J C Barrett; T R Devereux; T Ried
Journal:  Mol Carcinog       Date:  1997-08       Impact factor: 4.784

Review 6.  Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium.

Authors:  J L Burton; M Wells
Journal:  Histopathology       Date:  1998-10       Impact factor: 5.087

7.  Cytogenetics of uterine sarcomas: presentation of eight new cases and review of the literature.

Authors:  M Iliszko; N Mandahl; K Mrózek; A Denis; N Pandis; T Pejovic; M Babińska; B Nedoszytko; J Debniak; J Emerich; M Hrabowska; C D Bloomfield; J Limon
Journal:  Gynecol Oncol       Date:  1998-11       Impact factor: 5.482

8.  Microsatellite instability and somatic mutations in endometrial carcinomas.

Authors:  T Sakamoto; T Murase; H Urushibata; K Kato; H Takada; T Imamura; H Mori; N Wake
Journal:  Gynecol Oncol       Date:  1998-10       Impact factor: 5.482

9.  MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.

Authors:  M Esteller; R Levine; S B Baylin; L H Ellenson; J G Herman
Journal:  Oncogene       Date:  1998-11-05       Impact factor: 9.867

Review 10.  A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions.

Authors:  J Cuzick; P Sasieni; P Davies; J Adams; C Normand; A Frater; M van Ballegooijen; E van den Akker-van Marle
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640
View more
  2 in total

1.  Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview.

Authors:  I Tomlinson
Journal:  Mol Pathol       Date:  2001-08

Review 2.  Molecular alterations in the pathogenesis of endometrial adenocarcinoma. Therapeutic implications.

Authors:  Laura Cerezo; Higinia Cárdenes; Helen Michael
Journal:  Clin Transl Oncol       Date:  2006-04       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.